BD® Sepsis Management

The difference of helping clinicians set patients at risk for sepsis on the right clinical path
Current State

Sepsis is the most expensive in-patient cost in American hospitals (2013).1,2 Annual mortality from sepsis in the U.S. rivals deaths from prostate cancer, breast cancer and AIDS combined.1,4

$24 billion

Sepsis costs hospitals $24 billion each year 1

60 minutes

Every 1-hour delay in appropriate antibiotic treatment for septic shock increases mortality by 7.6% 3

250K deaths

Sepsis is responsible for over 250,000 deaths in the U.S. annually 1,2


At BD, we understand the challenges that sepsis presents to patient care.

Explore

Explore the BD Sepsis Management program

Download an overview of our BD Sepsis Management program for more information about how, together, we can help set patients at risk for sepsis on the right clinical path sooner.

Download

Program
Approach
Overview
Goals

Approach

Starting with a baseline assessment of current gaps, we’ll then outline how BD solutions can address these identified gaps and improve performance in people, processes and technologies. We'll review current sepsis protocols, practices and policies, from the recognition of a patient at risk for sepsis through treatment.

To have the greatest impact, metrics are aligned to the initiatives of our healthcare partners. Best practices are sustained through hospital champions, performance dashboards and ongoing education and training.

Our BD Sepsis Management program can help support your sepsis initiatives by optimizing the process from recognition to treatment for patients at risk for sepsis with the ultimate goal of improving patient outcomes.

Overview

BD Sepsis Management can help clinicians set patients on the right clinical path by reducing the time to accurately identify patients at risk for sepsis and those with bloodstream infections. Time is critical for these patients in order to provide the most effective sepsis treatment.

Goals

Reducing time to identification of patients at risk for sepsis, detection, lab turnaround time and time to appropriate therapy.

Improving collection of appropriate blood culture volumes and optimizing diagnostic accuracy.

Improving patient outcomes.

Program

BD Sepsis Management can help clinicians set patients on the right clinical path by reducing the time to accurately identify patients at risk for sepsis and those with bloodstream infections. Time is critical for these patients in order to provide the most effective sepsis treatment.

Approach

BD Sepsis Management from initial recognition to treatment

Every 20 seconds 1 person is diagnosed with sepsis in the U.S. 1,2

Sepsis is prevalent, the timely identification of a patient at risk for sepsis is necessary for setting the course of action to intervene with appropriate diagnosis and treatment.

Discover our Recognize technologies:

BD MedMined surveillance advisor »

~ 80% of skin flora reside in the first five layers of our outermost skin. 5

Proper skin preparation kills bacteria on the skin that can potentially cause skin infection and contamination.

Discover our Prep technologies:

ChloraPrep swabstick »

~ 20% of blood culture samples have been reported underfilled in the U.S. 6

Support optimal blood culture specimen collection; sufficient blood volume is a critical determinant for optimal organism recovery. The yield of pathogens recovered increases in direct proportion to the volume of blood cultured. 6

Discover our Collect technologies:

BD Vacutainer® UltraTouch push button blood collection set »

Reduction in transport time and faster incubation of blood cultures has been shown to reduce turnaround times and accelerate antibiotic switching. 7

Quickly implement optimal therapy, thereby positively affecting patient outcomes.

Discover our Transport technologies:

BD BACTEC FX40 blood culture instrument »

80% of sepsis deaths could be prevented by quicker diagnosis and treatment. 1

Decrease time to detection, followed by timely and accurate organism identification (ID) and antimicrobial susceptibility testing (AST).

Discover our Analyze technologies:

BD BACTEC blood culture media »

BD BACTEC FX blood culture system »

BD Kiestra lab automation system »

BD Phoenix automated identification and susceptibility testing system »

Mortality from septic shock increases 7.6% for every hour that treatment is delayed. 3
(Among patients with septic shock, within the first six hours of onset of hypotension)

Offer integrated workflow and on-demand insights to empower laboratory staff to impact turnaround time, expedite decision making, improve productivity and simplify compliance.

Discover our Report technologies:

BD Synapsys microbiology informatics solution »

5x reduction in survival when inappropriate initial antimicrobial therapy for septic shock, which occurs in ~20% of patients. 8

Accurate identification of patients at risk for sepsis, ensuring that appropriate diagnostics are performed as early as possible, enables timely and appropriate antimicrobial therapy treatment decisions.

Discover our Treat technologies:

BD MedMined surveillance advisor »

BD Phoenix automated identification and susceptibility testing »

Medication management solutions »

 
  1. Recognize
  2. Prep
  3. Collect
  4. Transport
  5. Analyze
  6. Report
  7. Treat

Contact us to discuss how we can support your sepsis initiatives

Contact us


References
  1. Sepsis Alliance: Sepsis Fact Sheet, 2016.
  2. HCUP Statisical Brief #204. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013. May 2016.
  3. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589-1596.
  4. HCUP Statistical Brief #122 Septicemia in U.S. Hospitals, 2009. Oct 2011.
  5. Brown E, Wenzel RP, Hendley JO. Exploration of the microbial anatomy of normal human skin by using plasmid profiles of coagulase-negative staphylococci: search for the reservoir of resident skin flora. J Infect Dis. 1989;160(4):644-650.
  6. Lamy B, Dargère S, Arendrup MC, Parienti J-J, Tattevin P. How to optimize the use of blood cultures for the diagnosis of bloodstream infections? A state-of-the art. Front Microbiol. 2016;7:697.
  7. Kerremans JJ, van der Bij AK, Goessens W, Verbrugh HA, Vos MC. Immediate incubation of blood cultures outside routine laboratory hours of operation accelerates antibiotic switching. J Clin Microbiol. 2009;47(11): 3520-3523.
  8. Kumar A, Ellis P, Aribi Y, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009; 136(5):1237-1248.

This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.